Carregant...
Next generation of biologics for the treatment of Crohn’s disease: an evidence-based review on ustekinumab
The limited efficacy of the currently available medical therapies in a proportion of patients with Crohn’s disease has led to the research and development of molecules that can block new inflammatory pathways. Ustekinumab is a fully human IgG1 monoclonal antibody which targets the common p40 subunit...
Guardat en:
| Publicat a: | Clin Exp Gastroenterol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697448/ https://ncbi.nlm.nih.gov/pubmed/29180886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S110546 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|